GlassScriptPhysician profile
Brian D Fedgchin
NPI 1336124221
$1,875.21
in general payments reported to CMS, 2019-2025
19 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $120 · 2021: $125 · 2022: $255 · 2023: $400 · 2024: $409 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $345.85 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $267.83 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $235.23 | 2022-2023 | Xarelto |
| Amgen INC. | $205.51 | 2019-2025 | Repatha |
| Novo Nordisk INC | $174.27 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $149.03 | 2021-2025 | Farxiga, Lokelma |
| Impulse Dynamics (USA) INC. | $100.63 | 2021-2023 | Optimizer |
| Pfizer INC. | $85.15 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $46.89 | 2024 | Verquvo |
| Edwards Lifesciences Corporation | $45.03 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inspire Medical Systems, INC. | $35.32 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $31.45 | 2023-2025 | Eliquis |
| Esperion Therapeutics, INC. | $27.81 | 2024 | Nexletol |
| Biohaven Pharmaceutical Holding Company LTD. | $27.38 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $23.12 | 2024 | Arcalyst |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $22.14 | 2019 | |
| Daiichi Sankyo INC. | $20.46 | 2022 | |
| Medicomp INC | $17.45 | 2025 | Telepatch Cardiac Monitor |
| Amarin Pharma, INC. | $14.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Fedgchin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.